BackElite Pharmaceuticals Overview

Elite Pharmaceuticals Research & Development

Research & Development expenses for ELTP.

Quarterly R&D Expenses

$1.04M
↓ 41.99% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$6.14M
↓ 19.61% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin